These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 1883848
21. Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: analysis by Western blot and immunohistochemistry. Suzuki K, Ito K, Kurokawa K, Suzuki T, Shimizu N, Fukabori Y, Honma S, Yamanaka H. Tohoku J Exp Med; 1997 Nov; 183(3):159-72. PubMed ID: 9550125 [Abstract] [Full Text] [Related]
22. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. Battmann T, Branche C, Bouchoux F, Cerede E, Philibert D, Goubet F, Teutsch G, Gaillard-Kelly M. J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):103-11. PubMed ID: 9569015 [Abstract] [Full Text] [Related]
23. Changes in the cytoplasmic androgen receptor of rat ventral prostate after administration of androgens, antiandrogens and anabolic steroids. Ichii S. Endocrinol Jpn; 1980 Aug; 27(4):483-93. PubMed ID: 7460859 [Abstract] [Full Text] [Related]
24. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells. Godoy-Tundidor S, Hobisch A, Pfeil K, Bartsch G, Culig Z. Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440 [Abstract] [Full Text] [Related]
25. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Dotzlaw H, Moehren U, Mink S, Cato AC, Iñiguez Lluhí JA, Baniahmad A. Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464 [Abstract] [Full Text] [Related]
27. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens. Kuil CW, Mulder E. Endocrinology; 1996 May; 137(5):1870-7. PubMed ID: 8612526 [Abstract] [Full Text] [Related]
28. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney. Kontula KK, Seppänen PJ, van Duyne P, Bardin CW, Jänne OA. Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747 [Abstract] [Full Text] [Related]
33. Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters. Simard J, Singh SM, Labrie F. Urology; 1997 Apr; 49(4):580-6; discussion 586-9. PubMed ID: 9111629 [Abstract] [Full Text] [Related]
38. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression. Fuse H, Korenaga S, Sakari M, Hiyama T, Ito T, Kimura K, Kato S. Prostate; 2007 May 01; 67(6):630-7. PubMed ID: 17342748 [Abstract] [Full Text] [Related]
40. Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate. Kondo Y, Homma Y, Aso Y, Kawabe K, Mieda M, Takahashi H. Prostate; 1996 Sep 01; 29(3):146-52. PubMed ID: 8827082 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]